Pro Medicus (OTCMKTS:PMCUF) Shares Up 5.1% – Should You Buy?

Pro Medicus Limited (OTCMKTS:PMCUF)’s share price rose 5.1% during trading on Tuesday . The company traded as high as $136.56 and last traded at $136.56. Approximately 25 shares were traded during mid-day trading, a decline of 96% from the average daily volume of 617 shares. The stock had previously closed at $129.94.

Analyst Ratings Changes

Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $155.00.

Pro Medicus Trading Up 13.0%

The stock has a fifty day moving average of $124.97 and a 200-day moving average of $105.70.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.